MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹5,664 Cr | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹5,664 Cr |
| Mar2024 | ₹2,120 Cr |
| Mar2023 | ₹1,863 Cr |
| Mar2022 | ₹2,623 Cr |
| Mar2021 | ₹1,353 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,664 Cr | 167.18 | |
| Mar2024 | ₹2,120 Cr | 13.77 | |
| Mar2023 | ₹1,863 Cr | -28.98 | |
| Mar2022 | ₹2,623 Cr | 93.84 | |
| Mar2021 | ₹1,353 Cr | - | |
Compare Total Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,213.2 Cr | -1% | 1.5% | -3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1% |
1.5% |
-3.8% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses